Drug Companies That Are High Medicare Earners Spend Big On Lobbying ActivitiesUSA Today: Some Top Medicare Beneficiaries Spend Heavily To Lobby
The 10 drug companies that make the most money from doctors using their products on Medicare patients spent more than $236 million to lobby Congress and the executive branch between 2009 and 2013, according to lobbying records compiled by the Center for Responsive Politics and new federal data. Those efforts came as lawmakers crafted the sweeping Affordable Care Act and as federal regulators have sought new ways to contain costs in Medicare, the federal insurance program for seniors (Kennedy, 4/24). This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.